Embecta

Embecta

Yahoo Finance • 18 hours ago

EMBECTA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Embecta Corp. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Embecta (EMBC) To Contact Him Directly To Discuss Their Options If you purchased or acquired Embecta common stock between November 2... Full story

Yahoo Finance • 2 days ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Embecta Corp. Common Stock and Sets a Lead Plaintiff Deadline of August 17, 2026

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock of Embecta Corp. (“Embecta” or the “Company”) (NA... Full story

Yahoo Finance • 3 days ago

embecta appoints Nimish Muzumdar as SVP and President, North America

Embecta Corp. PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today... Full story

Yahoo Finance • 14 days ago

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

NEW YORK, June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 22, 2026, to coincide with the... Full story

Yahoo Finance • 18 days ago

embecta to Participate in Investor Events

PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced th... Full story

Yahoo Finance • 21 days ago

EMBC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Embecta Corp.

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ:EMBC) investors concerning the Company’s and/or members of its sen... Full story

Yahoo Finance • last month

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification

Key Points Interested in Embecta Corp.? Here are five stocks we like better. Embecta reset its U.S. outlook after a tough quarter driven by share loss at a major retailer, softer insulin pen prescription trends, and inventory adjustments.... Full story

Yahoo Finance • last month

Embecta Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Embecta Corp. (NASDAQ: EMBC). The investigation focuses on Embecta’s executive officers and whether investor los... Full story

Yahoo Finance • last month

embecta Announces Quarterly Cash Dividend

Embecta Corp. PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.01 for each issued and outstanding share of the Company’s com... Full story

Yahoo Finance • 2 months ago

Yacktman Asset Management's Strategic Moves: A Closer Look at PayPal Holdings Inc.

This article first appeared on GuruFocus. Insightful Analysis of Yacktman Asset Management (Trades, Portfolio)'s Latest 13F Filing Is CNQ fairly valued? Test your thesis with our free DCF calculator. Yacktman Asset Management (Trades, P... Full story

Yahoo Finance • 2 months ago

Yacktman Fund's Strategic Moves: Significant Reduction in Samsung Electronics Co Ltd

This article first appeared on GuruFocus. Exploring Yacktman Fund (Trades, Portfolio)'s Recent Investment Adjustments Warning! GuruFocus has detected 4 Warning Signs with XPAR:BOL. Is XPAR:BOL fairly valued? Test your thesis with our fre... Full story

Yahoo Finance • 3 months ago

Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility

[Black Bull and Bear] peterschreiber.media/iStock via Getty Images Small-cap outperformance has narrowed over the last couple of weeks as investor caution increased, with volatility and geopolitical risk weighing on risk appetite and narr... Full story

Yahoo Finance • 4 months ago

embecta names new Chairman of the Board and Lead Independent Director

Embecta Corp. PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today... Full story

Yahoo Finance • 4 months ago

Embecta (EMBC) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. Date Thursday, Feb. 5, 2026 at 8 a.m. ET Call participants President and Chief Executive Officer — Devdatt Kurdikar Chief Financial Officer — Jake Elguicze Vice President, Investor Relations — Pravesh Kha... Full story

Yahoo Finance • 4 months ago

Yacktman Fund's Strategic Moves: A Closer Look at Samsung Electronics Co Ltd

This article first appeared on GuruFocus. Insights from the Fourth Quarter of 2025 Yacktman Fund (Trades, Portfolio) recently submitted the N-PORT filing for the fourth quarter of 2025, providing insights into its investment moves during... Full story

Yahoo Finance • 6 months ago

embecta to Participate at the J.P. Morgan 2026 Healthcare Conference

Embecta Corp. PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026... Full story

Yahoo Finance • 7 months ago

Stocks making the biggest moves midday: Dell, Arrowhead Pharmaceuticals, Urban Outfitters & more

Check out the companies making the biggest moves midday: Arrowhead Pharmaceuticals — The stock popped 19% after the biopharmaceutical company reported fiscal year revenue that beat analyst expectations. Arrowhead's top line for the period... Full story

Yahoo Finance • 7 months ago

Embecta declares $0.15 dividend

* Embecta (EMBC [https://seekingalpha.com/symbol/EMBC]) declares $0.15/share quarterly dividend [https://seekingalpha.com/pr/20319346-embecta-announces-quarterly-cash-dividend], in line with previous. * Forward yield [https://seekingal... Full story

Yahoo Finance • 7 months ago

Embecta gives mixed Q4 numbers, gives 2026 guidance

* Embecta press release [https://seekingalpha.com/pr/20319346-embecta-announces-quarterly-cash-dividend] (EMBC [https://seekingalpha.com/symbol/EMBC]): Q4 Non-GAAP EPS of $0.50 beats by $0.04. * Revenue of $263.3M (-8.0% Y/Y) misses by... Full story

Yahoo Finance • 7 months ago

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month periods ended September 30, 2... Full story